Bringing personalized care in Radiation Oncology towards ‘’minimum-achievable-risk’’ radiotherapy Every medical practice exhibits some degree of uncertainty. This is inevitably true in the case of Radiation Oncology. A technology enabling the minimization of such uncertainty results in safer and more effective treatments.

The core mission of RTsafe from its establishment was to develop and commercialize such technologies, enabling personalized care in radiation oncology, aiming for ‘’minimum-achievable-risk’’ radiotherapy.
LEARN MORE REQUEST A QUOTE

Personalized care in Radiation Oncology

During the first six years of its operations, RTsafe has focused mainly on brain cancer. PseudoPatient, nominated as one of the 100 most technologically significant products in 2019, is the personalized care solution that RTsafe has developed, patented and commercialized for brain tumor patients, following extensive R&D and tens of scientific publications. It is a 510k-FDA cleared solution that is already improving the lives of patients globally in a totally personalized way.

Our next core milestones are to make our personalized care solutions easily accessible to millions of cancer patients globally and to keep innovating and developing equivalent solutions for cancer types other than brain tumors.

At RTsafe, our goal is to develop and implement high-end technologies to achieve maximum treatment efficiency combined with maximum patient safety, allowing the patient to return to life’s activities, following an effective treatment.

Whatever role you play in the treatment cycle, RTsafe’s products and services can help you. Click on the button below to learn more about the benefits we can bring to you and your colleagues.

Find out how RTsafe can help you

Lorem Ipsum is simply dummy text of the printing and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

Lorem Ipsum is simply dummy text of theprinting and typesetting industry.

Learn how our technology changes the way
you work.

The PseudoPatient® solution

Play Video

See what's new at RTsafe

RTsafe & Mercurius Health launch a collaboration to promote safe and auditable SRS and SBRT/SABR treatments.

RTsafe & Mercurius Health launch a collaboration to promote safe and auditable SRS and SBRT/SABR treatments.

Announcements
Athens, Greece   –   November 9, 2020 RTsafe and Mercurius Health today proudly announced that they have launched a collaboration based...
Read More
Webinar – Prime Phantom – Periodic End-To-End QA in SRS

Webinar – Prime Phantom – Periodic End-To-End QA in SRS

Webinars
Join our webinar on October 16, at 16:00 EEST lead by Prof. Niko Papanikolaou, titled “Prime Phantom – Periodic End-To-End...
Read More
RTsafe to exhibit at ASTRO 2020

RTsafe to exhibit at ASTRO 2020

Conferences - Tradeshows
ASTRO 2020 will be held between October 23-28, 2020 this time virtually! We are delighted to be a part of...
Read More

Testimonials

Download our complete
product cataloque.

Request a quote

End Users

Customers Placeholder
Customers